USA
We have documented a detrimental effect of mild hypoglycemia (HYPO) on cognitive function in children with IDDM. A similar eflect lios been postulated, but not verified, for hyperglycemia (HYPER) or its recovery to euglycemia (EU). We compared cognitive performance, measured by Choice Reaction Time (CRT) & Trailmaking-B (TMB). during HYPO, HYPER & EU, under hyperinsulinemic (9OpUiml) ciamp conditions in 44 children aged (9-19) yrs with IDDM duration 812.6-15) yrs. Tests for CRT, TMB & PP were performed at baseline (PG 5.5mM, period I) in ail 3 groups & repeated at the same intervals: periods II & Ill at 5 & 45 min of HYPO (PG 3.3mM, n=2O) HYPER (PG 20mM, n=13) 
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A cytokine link between the environment and the immune system in Type I diabetes. J.A. S t w . 8 Hultgren, X Huang, S Pitts-Meek, J Hully and J. MacLachlin. Genentech Inc., South San Francisco, CA 94080 USA Type I diabetes is caused by an auto immune mediated destruction of the insulin producing pancreatic beta cells. Although particular alleles at the MHC iocus can markedly increase the risk of developing diabetes, the discordance rate in identical siblings is greater than 50%. Thus, the disease process appears to involve an interaction between the environment (possibly a viral infection), the pancreatic beta cells and the immune system in a genetically susceptible host. We have tested several hypotheses that could explain this interaction by generating transgenic mice in which the beta cells express specific proteins. Several lines of transgenic mice were generated in which the beta cells express a cytokine that is induced by environmental stresses and that is expressed by the beta cells of patients with recent onset Type I diabetes. These transgenic mice develop a pathology that closely resembles Type I diabetes. We have also successfully prevented the diabetes in these mice using a monoclonal antibody directed against the cytokine. Research Genentech, inc.: J~e~t ol Preventive Medicme. SUNYAB Plasma IGF-l levels have been shown to be low in selected patienls with poorly controlled IDDM The aim of this study was to determine the prevalence of depressed IGF-I levels and lo correlate these values to metabolic control in a larger cohort of IDDM patients. Data were collected from 65 randomly selected patients on conventional insulin Rx, followed in a university-based diabetes clinic, age 6-21 years, duration 68+6 months, The data are expressed as mean + SEM and Mann-Whitney U was used for statistical analysis. The patients were divided on the basis of their glycated Hemoglobin (HbAt) 2 11% and 5 10.9% (nt HbAl 6.6-8.8%). IGF-I was determined by RIA (Endocrine Science) after acidiethanol extraction; relerence values were adjusted for age and Tanner stage. "Low" IGF-I level was delined as a value lower than -1SD from Ihe mean.
RESULTS: N Aoe
Insulin Dose Cholesterol IGF-1 % of low 6 ) IuIkg)
IGF-1 H b A l s 1 0 8 40 1 3 2 2 6 ' 3 2 0 4 18OfG 332220 23% H b A l~1 1 . 0 25 1 3 . 7 2 9 9 2 0 5 1 9 2 2 9 298228 48% The prevalence of low IGF-I levels is signiflcantiy higher in patients with HbAl 21 1% (p<O 05). In addition thore was a correlation between HbAl and cholesterol levels (r=O 25). but no correlation between the latler and iGF-I was observed Conclusions: These data suggest that a decrease in plasma IGF-I levels is a common finding in pooriy controlled IDDM. it is yet to be shown in a controlled, prospective trial whether improved metabolic control can increase circulating IGF-I or, conversely, whether administration of recombinant IGF-I can improve metabolic control. T o s t u d y Lhc effect o f Keloacidosis(KA) a n d chronic loss of calories(glycose) on ICI:-l synlhesis, L3-11ydroxybi11yrate(B-III1) and I l b A l C were compared i n 3 groups oi c l~i l d r c n wit11 identical mean cl~ronologic age(l0.4Y~3.6Y/lOY?2.5Y): nornial children, children w i t h "conlroled" type 1 diabetes, and children w i t h diabetic K A . Each group was composed b y 19 children. I n n o r m a l controls, IGF-1 was signiflcanlly higher kllaii i n "controled" diabetics(t=2.23;p=0.04) and i n KA(t=-5.22;p=0 0001). U-110 concentration was similar i n normal conlrols and i n "controlecl" diabetics, but significantly higher i n KA(t=-5;p=0.0002). N o corrclalion between 0-1111 and I(;[:-1, i n KA, was observed. G r o w t h Iiormone (GI!) was significantly more elevated i n K A than i n normal controls (I=-1.9;p=0.03). I~I b A l C values wcrc significantly higher 111 "controled" diabelics than i n n o r n i a l children(4.3%i0.7% / 7.2%+1.5% -t=-7.4; p=0.0001). The samples arc relatively small, b u l its anaiysis suggests that 1CI:-1 syntl~esis, iri type I diabetes, is mainly nffccted by t l~c "invisible chronic inalnutr~lioir"; despite high GI-I concentralioi~ i n KA, IGF-1 syntl~esis secms to be inhibited b y the cellular malnutrit~on, IGF-I, probabily, is also an efficient parameter for n>clnbolic conlrol i n this disease. K A secms not to affect IGF-1 synthesis.
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'TIIE ROLE OF SOMA' TCl I.ACTOGCNIC IIORMONES AND RCCCI' TORS I N 'TtiE GROWTI 1 AND FUNCTION OF THE ENDOCRINE PANCREAS. J.li. Nielsen, A . Moldrup, N. B i l l e s t r u p and E.D. Petersen, iiagedorn Research l n s t i tute, DK-2820 Gentofte, Denmark.
Glowth Iloiino~le (GII) and p,olactitt (PRL) are dinbetogenic i n humans, but not i n rais. We have previollsly demonstrated that Gli, PRL and placental lactogeii (PI.) stimulates lhoth p r o l i f e r a t i o n and i ns u l i n pr-oduction i n isolated rat i s l e t s i n c u l t t l~e . The a i m of the present study was to test wlietl~e~ GI1 ilifluences the function of isolated human i s l e t s i n culture. I s l e t s were ohtained by collagenase d i~e~t i o l l 01 pancleat i c t i~s c~c obtainetl I L O~ (light cnecrokidney donors aged 12 to 58. Groups of 50 i s l e t s were cultured i n R P N I 1640 supplemented with 0.5% normal human serum with or without 1 vg/ml hCl1. I n s u l i n was measured i n the medium during a culture per i o d of 7 or 14 days. The accumulated i n s u l i n release varied between 5 . 4 and 7 1 . 1 ng per i s l e t pel week. I s l e t s from two donors showed n o i~icrensc i l l tesponnc. L O l;ll, f ivc. 5tlnwed a rmi odes t inct ease (3.1-7.7 n~) and otlly o n e , a 17-year old g i r -I , showed a marked i ncrease (29.9 ng). As the human i n s u l i n gene promoter contains a putative GH-respo~lsive element similar to tllat of the rat genes the variation i n :espon.;ivcne?s s a y be due t o a n s g r nnd sen-dependent v a r i a t i o n i l l the nuli~br?t o f C i l and PRI. ~rercptots. We a l e at plesent measuring the expression of the LeceptoL genes i n lhornnn i s l e t s . I n conclusion Ihe l e s u l l s suppol t thc l,ypotliesis that the diabe~ogenic effect of the somatolactogenir hormones i n adult man i s due to an age-dependent decrease i n the recponsiveness o i the pancreatic 0 r o l l s to the tl.oi,llir rf f r c i r i i Ilie:.~ I!olimov,es.
